679
Views
10
CrossRef citations to date
0
Altmetric
Letter to the Editor

Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma

, , , , , , , , & show all
Pages 511-514 | Received 09 Dec 2017, Accepted 27 Apr 2018, Published online: 08 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ravi Kumar Gupta, Ashish Gupta, Jens Hillengass, Sarah A. Holstein, Vera J. Suman, Alankrita Taneja & Philip L. McCarthy. (2022) A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022. Expert Review of Anticancer Therapy 22:5, pages 457-469.
Read now
Sonia Morè, Laura Corvatta, Laura Maracci, Benedetta Costantini, Attilio Olivieri & Massimo Offidani. (2020) Developments in consolidation and maintenance strategies in post-remission multiple myeloma. Expert Review of Hematology 13:4, pages 351-362.
Read now

Articles from other publishers (8)

Paul G. RichardsonSusanna J. JacobusEdie A. WellerHani HassounSagar LonialNoopur S. RajeEva MedvedovaPhilip L. McCarthyEdward N. LibbyPeter M. VoorheesRobert Z. OrlowskiLarry D. AndersonJr.Jr., Jeffrey A. ZonderCarter P. MilnerCristina GasparettoMounzer E. AghaAbdullah M. KhanDavid D. HurdKrisstina GowinRammurti T. KambleSundar JagannathNitya NathwaniMelissa AlsinaR. Frank CornellHamza HashmiErica L. CampagnaroAstrid C. AndreescuTeresa GentileMichaela LiedtkeKelly N. GodbyAdam D. CohenThomas H. OpenshawMarcelo C. Pasquini, Sergio A. GiraltJonathan L. KaufmanAndrew J. YeeEmma ScottPallawi TorkaAmy FoleyMariateresa FulcinitiKyle HebertMehmet K. SamurKelly MasoneMichelle E. MaglioAndrea A. ZeytoonjianOmar NadeemRobert L. SchlossmanJacob P. LaubachClaudia Paba-PradaIrene M. GhobrialAurore PerrotPhilippe MoreauHervé Avet-LoiseauMichel AttalKenneth C. AndersonNikhil C. Munshi. (2022) Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma. New England Journal of Medicine 387:2, pages 132-147.
Crossref
Joana Caetano, Filipa Barahona, Paulo Lúcio & Cristina João. (2022) Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?. Hemato 3:3, pages 385-413.
Crossref
Sarah Farag, Ulrike Bacher, Barbara Jeker, Myriam Legros, Gaelle Rhyner, Jean-Marc Lüthi, Julian Schardt, Thilo Zander, Michael Daskalakis, Behrouz Mansouri, Chantal Manz & Thomas Pabst. (2022) Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial. Bone Marrow Transplantation 57:6, pages 990-997.
Crossref
Matthew Ho, Saurabh Zanwar, Prashant Kapoor, Morie Gertz, Martha Lacy, Angela Dispenzieri, Suzanne Hayman, David Dingli, Francis Baudi, Eli Muchtar, Nelson Leung, Taxiarchis Kourelis, Rahma Warsame, Amie Fonder, Lisa Hwa, Miriam Hobbs, Robert Kyle, S. Vincent Rajkumar & Shaji Kumar. (2021) The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM). Blood Cancer Journal 11:9.
Crossref
Christophe Betticher, Ulrike Bacher, Myriam Legros, Stefan Zimmerli, Yara Banz, Behrouz Mansouri Taleghani & Thomas Pabst. (2020) Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation. Hematological Oncology 39:1, pages 97-104.
Crossref
Rafael Alonso, María-Teresa Cedena, Sandy WongNina ShahRafael Ríos-Tamayo, José M. Moraleda, Javier López-Jiménez, Cristina GarcíaNatasha BahriAntonio ValeriRicardo Sánchez, Luis Collado-Yurrita, Thomas MartinJeffrey WolfJuan-José Lahuerta & Joaquín Martínez-López. (2020) Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma. Blood Advances 4:10, pages 2163-2171.
Crossref
Parameswaran Hari, Brian Ung, Safiya Abouzaid, Amit Agarwal & Kejal Parikh. (2019) Lenalidomide maintenance post-transplantation in newly diagnosed multiple myeloma: real-world outcomes and costs. Future Oncology 15:35, pages 4045-4056.
Crossref
. (2019) Lenalidomide. Reactions Weekly 1755:1, pages 196-196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.